KEVIN GAREY to United States
This is a "connection" page, showing publications KEVIN GAREY has written about United States.
Connection Strength
0.287
-
Antibiotic utilization within 18 community hospitals in the United States: A 5-year analysis. Pharmacoepidemiol Drug Saf. 2021 04; 30(4):403-408.
Score: 0.057
-
Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA. J Glob Antimicrob Resist. 2018 12; 15:41-47.
Score: 0.048
-
Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection. Antimicrob Agents Chemother. 2017 06; 61(6).
Score: 0.045
-
Education, training, and academic experience of newly hired, first-time pharmacy faculty members. Am J Pharm Educ. 2014 Jun 17; 78(5):92.
Score: 0.036
-
Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010 Apr; 74(4):309-18.
Score: 0.027
-
Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines. Pharmacoepidemiol Drug Saf. 2007 Aug; 16(8):919-27.
Score: 0.023
-
Association Between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes Among Hospitalized Adult Patients With Candidemia Who Received Empiric Treatment With an Echinocandin Across United States Hospitals. Clin Infect Dis. 2026 Feb 09; 82(1):75-85.
Score: 0.020
-
Surveillance of Clostridioides difficile Antimicrobial Resistance in the United States. Clin Infect Dis. 2023 06 08; 76(11):2038-2039.
Score: 0.017
-
A multisite genomic epidemiology study of Clostridioides difficile infections in the USA supports differential roles of healthcare versus community spread for two common strains. Microb Genom. 2021 06; 7(6).
Score: 0.015